Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Activist investor Mick McGuire's hedge fund Marcato Capital Management came out against Canopy Growth Corp.'s acquisition of Acreage Holdings Inc. in a letter sent to Acreage's board of directors.

Activist Investor Mick McGuire Opposes Acreage-Canopy Growth Deal

HEXO Corp

Constellation Brands

22nd Century Group

Despite a rare down month for pot stocks as a whole, these 10 companies finished April higher by at least 15%.

The 10 Best Marijuana Stocks in April

Aurora Cannabis

Cronos Group

If you had the foresight, and stomach, to invest in popular pot stocks early, you'd be rolling in the green today.

Investing $1,000 in Aurora, Canopy, and Cronos in 2016 Would Be Worth This Much Today

GW Pharmaceuticals

Tilray Brands

Two marijuana stocks currently have at least $1.8 billion in cash and cash equivalents at their disposal.

These 5 Pot Stocks Have the Most Cash

Support is building for changing federal marijuana laws in the U.S. But here's what could derail legalization efforts.

The 4-Letter Word That Could Prevent U.S. Marijuana Legalization

The top cannabis grower's stock continued its strong 2019 performance, thanks to a strategic move in the U.S. marijuana space.

Why Canopy Growth Stock Jumped 16.5% in April

Curaleaf Holdings, Inc.

Curaleaf Chairman Boris Jordan just dished on a metric that all pot stock investors need to know.

This Is the Single Most Important Statement Made by a Marijuana Stock Executive All Year

Neptune Wellness Solutions Inc.

These pot stocks soared last month, and two still look like great picks for investors.

5 Best Pot Stocks in April -- Are They Buys Now?

Aphria

Which of these leading Canadian cannabis growers is the better investment for the long term?

Better Marijuana Stock Buy: Canopy Growth vs. Aphria

Canopy Growth Corp is strengthening its presence in Germany and Europe with the acquisition of C3 Cannabinoid Compound Company, a leading manufacturer and distributor of dronabinol, a synthetic cannabinoid.

Canopy Growth Acquires Germany-Based C3 Cannabinoid Compound Company For $254M

The smaller Canadian marijuana producer's success in its latest quarter could bode well for the industry's two biggest players.

Could Organigram's Q2 Results Hint at What's to Come for Aurora Cannabis and Canopy Growth?

CannTrust Holdings

If you're hunting pot stocks with the best chance of turning rising sales into shareholder profit, you ought to consider these stocks.

These Top Marijuana Stocks Have the Best Profit Margin

Hilary Black founded Canada's first marijuana dispensary in the late 1990s and was "willing to go to jail.

From 'Willing To Go To Jail' To C-Suite Cannabis Exec: Bloomberg Profiles Canopy's Hilary Black

You'll never guess the company with the second most adult-use sales.

3 Pot Stocks Selling the Most Recreational Marijuana

Canadian pot producer Canopy Growth said it had nailed down a facility in New York state as part of its plans to build a hemp-production park there.

Canopy Growth Breaks Out After Hemp Deal

Canopy Growth Corp's plans to build a Hemp Industrial Park in New York are in full swing.

Canopy Growth Acquires NY Facility For Hemp Industrial Park

MedMen Enterprises Inc.

Trulieve Cannabis Corp.

You'll find plenty of growers and dispensary operators among the largest marijuana stocks.

Meet Marijuana's 14 Billion-Dollar Pot Stocks

It's only a matter of time before our neighbor to the south becomes the third country worldwide to green-light adult-use cannabis.

Mexico Aims to Legalize Recreational Marijuana Before October

Find out which companies are wholly focused on the adult-use market, and which surprising name believes medical cannabis is the future.

Marijuana Stocks: Breaking Down the Recreational-to-Medical Sales Ratio of the Top Growers

Canopy Growth's groundbreaking deal to buy Acreage Holdings provides no added indications that cannabis legalization is imminent in the United States.

Don't Be Fooled by the Canopy-Acreage Deal -- Marijuana Legalization Is No Sure Thing

Canadian pot sales in February were 13% lower than in December.

Uh-Oh! Canadian Marijuana Sales Have Declined 2 Straight Months

Desjardins marches into a surging pot market with buy ratings for HEXO, Aurora Cannabis, and Canopy Growth.

News for Canopy Growth Stock (CGC)